First, it could hit 0.1c. Then, consolidation 1 for 10. Theoretically it should re-open at 1c but due to the problems it will re-open at 0.7c / 0.8c. Then, if nothing changes, back to 0.1c post consolidation or at 0.01c pre- consolidation.
The problems have been outlined but people are too blind to accept it:
1. 9 trial sites for GBM CAR-T trial were planned by JC - suddenly there is hardly any available due to lack of trained personnel
Ok, but if that was the only problem and not the CLTX-tech itself someone would have the, Gold Standard exceeding, tech snapped up, right? - No, not one tiny bit of interest.
2. The AML-NK trials seem to deliver good results, but why hasn't anyone knocked on the door to grab those?
3. CDH17 was THEEEEEEEEEEEEEEEEE praised tech to kill solid gastric-type cancers. Again, not one offer. Dr Bec was told by her Pharma-friends to get at least 6 patients dosed to establish a safety profile and an OBD, then they may or may not have some discussions.
4. PH seemed to have lined up an 800m share investor / group for a CR. They pulled the plug and he couldn't find anyone else since mid August when it became obvious that the CR failed.
5. 0.8c emergency CR was explained as ....." There was no better way ...."
The above should be enough to raise concerns and the current sell-off by the 0.8c sophies confirms that. I was told to get help - is it really me who should seek help?
CHM Price at posting:
0.7¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)